192 related articles for article (PubMed ID: 18616708)
1. Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial.
Burnett-Bowie SA; Roupenian KC; Dere ME; Lee H; Leder BZ
Clin Endocrinol (Oxf); 2009 Jan; 70(1):116-23. PubMed ID: 18616708
[TBL] [Abstract][Full Text] [Related]
2. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
Leder BZ; Rohrer JL; Rubin SD; Gallo J; Longcope C
J Clin Endocrinol Metab; 2004 Mar; 89(3):1174-80. PubMed ID: 15001605
[TBL] [Abstract][Full Text] [Related]
3. Somatic and psychological effects of low-dose aromatase inhibition in men with obesity-related hypogonadotropic hypotestosteronemia.
Loves S; de Jong J; van Sorge A; Telting D; Tack CJ; Hermus A; Westerterp K; de Boer H
Eur J Endocrinol; 2013 Nov; 169(5):705-14. PubMed ID: 23949882
[TBL] [Abstract][Full Text] [Related]
4. Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.
Leder BZ; Finkelstein JS
Osteoporos Int; 2005 Dec; 16(12):1487-94. PubMed ID: 15856361
[TBL] [Abstract][Full Text] [Related]
5. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels.
Burnett-Bowie SA; McKay EA; Lee H; Leder BZ
J Clin Endocrinol Metab; 2009 Dec; 94(12):4785-92. PubMed ID: 19820017
[TBL] [Abstract][Full Text] [Related]
6. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
Dougherty RH; Rohrer JL; Hayden D; Rubin SD; Leder BZ
Clin Endocrinol (Oxf); 2005 Feb; 62(2):228-35. PubMed ID: 15670201
[TBL] [Abstract][Full Text] [Related]
7. The role of aromatization in testosterone supplementation: effects on cognition in older men.
Cherrier MM; Matsumoto AM; Amory JK; Ahmed S; Bremner W; Peskind ER; Raskind MA; Johnson M; Craft S
Neurology; 2005 Jan; 64(2):290-6. PubMed ID: 15668427
[TBL] [Abstract][Full Text] [Related]
8. Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism.
Loves S; Ruinemans-Koerts J; de Boer H
Eur J Endocrinol; 2008 May; 158(5):741-7. PubMed ID: 18426834
[TBL] [Abstract][Full Text] [Related]
9. Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial.
Dias JP; Melvin D; Simonsick EM; Carlson O; Shardell MD; Ferrucci L; Chia CW; Basaria S; Egan JM
Andrology; 2016 Jan; 4(1):33-40. PubMed ID: 26588809
[TBL] [Abstract][Full Text] [Related]
10. Coadministration of anastrozole sustains therapeutic testosterone levels in hypogonadal men undergoing testosterone pellet insertion.
Mechlin CW; Frankel J; McCullough A
J Sex Med; 2014 Jan; 11(1):254-61. PubMed ID: 24119010
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up.
Behre HM; Tammela TL; Arver S; Tolrá JR; Bonifacio V; Lamche M; Kelly J; Hiemeyer F; ; Giltay EJ; Gooren LJ
Aging Male; 2012 Dec; 15(4):198-207. PubMed ID: 22834649
[TBL] [Abstract][Full Text] [Related]
12. A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism.
Herzog AG; Farina EL; Drislane FW; Schomer DL; Smithson SD; Fowler KM; Dworetzky BA; Bromfield EB
Epilepsy Behav; 2010 Feb; 17(2):264-71. PubMed ID: 20096638
[TBL] [Abstract][Full Text] [Related]
13. The effects of the aromatase inhibitor anastrozole on bone metabolism and cardiovascular risk indices in ovariectomized, androgen-treated female-to-male transsexuals.
Bunck MC; Toorians AW; Lips P; Gooren LJ
Eur J Endocrinol; 2006 Apr; 154(4):569-75. PubMed ID: 16556720
[TBL] [Abstract][Full Text] [Related]
14. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
15. Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.
Juang PS; Peng S; Allehmazedeh K; Shah A; Coviello AD; Herbst KL
J Sex Med; 2014 Feb; 11(2):563-73. PubMed ID: 24344872
[TBL] [Abstract][Full Text] [Related]
16. Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial.
Shah S; Bell RJ; Savage G; Goldstat R; Papalia MA; Kulkarni J; Donath S; Davis SR
Menopause; 2006; 13(4):600-8. PubMed ID: 16837882
[TBL] [Abstract][Full Text] [Related]
17. Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism.
de Boer H; Verschoor L; Ruinemans-Koerts J; Jansen M
Diabetes Obes Metab; 2005 May; 7(3):211-5. PubMed ID: 15811136
[TBL] [Abstract][Full Text] [Related]
18. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.
Emmelot-Vonk MH; Verhaar HJ; Nakhai Pour HR; Aleman A; Lock TM; Bosch JL; Grobbee DE; van der Schouw YT
JAMA; 2008 Jan; 299(1):39-52. PubMed ID: 18167405
[TBL] [Abstract][Full Text] [Related]
19. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.
Page ST; Amory JK; Bowman FD; Anawalt BD; Matsumoto AM; Bremner WJ; Tenover JL
J Clin Endocrinol Metab; 2005 Mar; 90(3):1502-10. PubMed ID: 15572415
[TBL] [Abstract][Full Text] [Related]
20. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.
Kenny AM; Prestwood KM; Gruman CA; Marcello KM; Raisz LG
J Gerontol A Biol Sci Med Sci; 2001 May; 56(5):M266-72. PubMed ID: 11320105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
